SERPINF2 and cholestasis: For the evidence that activated cholangiocytes-provoked recruitment and activation of macrophages promotes cholestasis and injury during the progression of biliary diseases [26,27], we supposed that Api could suppress the activation of macrophages by inhibiting upstream PANoptopsis signaling of CDCA-treated HIBEC cells.